These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 2254635)

  • 1. Criteria of drug-induced liver disorders. Report of an international consensus meeting.
    Bénichou C
    J Hepatol; 1990 Sep; 11(2):272-6. PubMed ID: 2254635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced liver disorders: report of an international consensus meeting.
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):317-22. PubMed ID: 2272712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of definitions and criteria of causality assessment of adverse drug reactions. Drug-induced cytopenia.
    Int J Clin Pharmacol Ther Toxicol; 1991 Feb; 29(2):75-81. PubMed ID: 2026468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting.
    Benichou C; Solal Celigny P
    Nouv Rev Fr Hematol (1978); 1991; 33(3):257-62. PubMed ID: 1956763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
    Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
    Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?
    Danan G; Teschke R
    Drug Saf; 2018 Aug; 41(8):735-743. PubMed ID: 29502198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury.
    García-Cortés M; Lucena MI; Pachkoria K; Borraz Y; Hidalgo R; Andrade RJ;
    Aliment Pharmacol Ther; 2008 May; 27(9):780-9. PubMed ID: 18284654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug-induced renal insufficiency. Results of consensus meetings].
    Vigeral P; Baumelou A; Bénichou C; Castot A; Danan G; Kreft-Jais C; Lagier G; Rothschild E; Druet P; Grünfeld JP
    Nephrologie; 1989; 10(3):157-61. PubMed ID: 2691914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Criteria of imputation of acute hepatitis to a drug. Results of consensus meetings].
    Danan G; Bénichou C; Begaud B; Biour M; Couzigou P; Evreux JC; Lagier G; Berthelot P; Benhamou JP
    Gastroenterol Clin Biol; 1987; 11(8-9):581-5. PubMed ID: 3308618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causality assessment methods in drug induced liver injury: strengths and weaknesses.
    García-Cortés M; Stephens C; Lucena MI; Fernández-Castañer A; Andrade RJ
    J Hepatol; 2011 Sep; 55(3):683-691. PubMed ID: 21349301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and reproducibility of two scales in causality assessment of unexpected hepatotoxicity.
    Miljkovic MM; Dobric S; Dragojevic-Simic V
    J Clin Pharm Ther; 2012 Apr; 37(2):196-203. PubMed ID: 21718339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International reporting on adverse drug reactions: the CIOMS project. CIOMS ADR Working Group.
    Faich GA; Castle W; Bankowski Z
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):133-8. PubMed ID: 2338366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [International reporting of adverse drug reactions. Final report of CIOMS ADR Working Group].
    Royer RJ; Benichou C
    Therapie; 1991; 46(3):173-8. PubMed ID: 1792648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Criteria for assessing granulocytic or platelet cytopenia caused by drugs. Results of consensus meetings].
    Solal-Céligny P; Benichou C; Boivin P; Castot A; Coulombel L; Danan G; Degos L; Evreux JC; Lagier G; Lavarenne J
    Nouv Rev Fr Hematol (1978); 1987; 29(4):265-70. PubMed ID: 3320952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacovigilance and herbal hepatotoxicity: critical aspects and solutions].
    Teschke R; Schulze J
    Dtsch Med Wochenschr; 2013 Feb; 138(6):281-4. PubMed ID: 23361353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
    Teschke R
    Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Montelukast induced acute hepatocellular liver injury.
    Harugeri A; Parthasarathi G; Sharma J; D'Souza GA; Ramesh M
    J Postgrad Med; 2009; 55(2):141-2. PubMed ID: 19550064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate?
    Teschke R; Wolff A
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):1-7. PubMed ID: 20854865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (XII): collagen disorders and musculo-skeletal disorders.
    Council for International Organizations of Medical Sciences
    Pharmacoepidemiol Drug Saf; 1999 Mar; 8(2):141-5. PubMed ID: 15073939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definitions and basic requirements for the use of terms for reporting adverse drug reactions (X): gastrointestinal system disorders.
    Pharmacoepidemiol Drug Saf; 1998 Jul; 7(4):281-7. PubMed ID: 15073991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.